Carla Lubrano
Overview
Explore the profile of Carla Lubrano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
1862
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Masi D, Gangitano E, Criniti A, Ballesio L, Anzuini A, Marino L, et al.
Viruses
. 2023 Feb;
15(2).
PMID: 36851702
The full spectrum of SARS-CoV-2-infected patients has not yet been defined. This study aimed to evaluate which parameters derived from CT, inflammatory, and hormonal markers could explain the clinical variability...
12.
Frigerio F, De Marinis M, Camardella F, Cantisani V, Pinto A, Bernardi M, et al.
Biomedicines
. 2023 Feb;
11(2).
PMID: 36831008
Accumulating evidence supports a connection between sarcopenic obesity (SO) and NAFLD. The extent to which fatty liver contributes to impaired muscle contractility is not yet well established. The aim of...
13.
Ernesti I, Baratta F, Watanabe M, Risi R, Camajani E, Persichetti A, et al.
Front Nutr
. 2023 Feb;
10:1058364.
PMID: 36761216
Introduction: The Very Low-Calorie Ketogenic Diet (VLCKD) has emerged as a safe and effective intervention for the management of metabolic disease. Studies examining weight loss predictors are scarce and none...
14.
Tozzi R, Campolo F, Baldini E, Venneri M, Lubrano C, Ulisse S, et al.
Int J Mol Sci
. 2022 Dec;
23(24).
PMID: 36555502
Overnutrition and its sequelae have become a global concern due to the increasing incidence of obesity and insulin resistance. A ketogenic diet (KD) is widely used as a dietary treatment...
15.
Barchetta I, Lubrano C, Cimini F, Dule S, Passarella G, Dellanno A, et al.
Hepatol Int
. 2022 Dec;
17(2):357-366.
PMID: 36520377
Background And Purpose: Chronic liver diseases are associated with increased bone fracture risk, mostly in end-stage disease and cirrhosis; besides, data in non-alcoholic fatty liver disease (NAFLD) are limited. Aim...
16.
Marino L, Criniti A, Guida S, Bucci T, Ballesio L, Suppa M, et al.
Clin Exp Med
. 2022 Nov;
23(4):1243-1250.
PMID: 36385417
The immune response to the SARS-CoV-2 infection is crucial to the patient outcome. IL-18 is involved in the lymphocyte response to the disease and it is well established its important...
17.
Bellini M, Urciuoli I, Del Gaudio G, Polti G, Iannetti G, Gangitano E, et al.
World J Diabetes
. 2022 Oct;
13(9):668-682.
PMID: 36188142
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease in the world and represents a clinical-histopathologic entity where the steatosis component may vary in degree and may...
18.
Tozzi R, Cipriani F, Masi D, Basciani S, Watanabe M, Lubrano C, et al.
Nutrients
. 2022 Aug;
14(15).
PMID: 35956321
Ketone bodies (KBs) and Sirtuin-1 (SIRT1) have received increasing attention over the past two decades given their pivotal function in a variety of biological contexts, including transcriptional regulation, cell cycle...
19.
Gangitano E, Barbaro G, Susi M, Rossetti R, Spoltore M, Masi D, et al.
Cells
. 2022 Aug;
11(15).
PMID: 35954264
Obesity is associated with increased cardiovascular morbidity. Adult patients with growth hormone deficiency (GHD) show morpho-functional cardiological alterations. A total of 353 overweight/obese patients are enrolled in the period between...
20.
Camajani E, Persichetti A, Watanabe M, Contini S, Vari M, Di Bernardo S, et al.
Nutrients
. 2022 May;
14(9).
PMID: 35565851
In sarcopenic obese subjects it is essential to reduce body weight and preserve lean mass, in order to avoid a worsening of muscle function. Several studies have shown that leucine...